CONSOLIDATION THERAPY: Beginning 6 weeks after achieving complete remission (CR)/CR with incomplete count recovery (CRi), patients receive decitabine, filgrastim, cladribine and cytarabine as in Arm I. Treatment repeats every 10 days for up to 4 courses in the absence of disease progression or unacceptable toxicity.